The construction of hierarchical assemblies with in situ generation of chemotherapy drugs to enhance the efficacy of chemodynamic therapy for multi-modal anti-tumor treatments

文献信息

发布日期 2023-10-25
DOI 10.1039/D3TB01564E
影响因子 6.331
作者

Wei-Nan Zhao, Hongjuan Li, Shiguo Sun, Yongqian Xu


查看原文

摘要

The effectiveness of chemodynamic therapy (CDT) in cancer treatment is limited by insufficient endogenous H2O2 levels in tumor tissue and an increasing ratio of high valence metal ions. To overcome these challenges, a novel nanotherapeutic approach, named GOx-CuCaP-DSF, has been proposed. This approach involves the design of nanotherapeutics that aim to self-supply H2O2 within cancer cells and provide a supplement of low valence metal ions to enhance the performance of CDT. GOx-CuCaP-DSF nanotherapeutics are engineered by incorporating glucose oxidase (GOx) into Ca2+-doped calcium phosphate (CaP) nanoparticles and loading disulfiram (DSF) through surface adsorption. Under the tumor microenvironment, GOx catalyzes the conversion of tumor-overexpressed glucose (Glu) to liberate H2O2. The degradation of CaP further lowers the pH, facilitating the release of Cu2+ ions and DSF. The rapid reaction between Cu2+ and DSF leads to the generation of Cu+, increasing the Cu+/Cu2+ ratio and promoting the Cu+-based Fenton reaction, which enhances the efficiency of CDT. Simultaneously, DSF undergoes conversion to diethyldithiocarbamate acid (ET), forming a copper(II) complex (Cu(II)ET) by strong chelation with Cu ions. This Cu(II)ET complex, a potent chemotherapeutic drug, exhibits a synergistic therapeutic effect in combination with CDT. Moreover, the elevated Cu+ species resulting from DSF reaction promotes the aggregation of toxic mitochondrial proteins, leading to cell cuproptosis. Overall, the strategy of integrating the chemodynamic therapy efficiency of the Fenton reaction with the activation of efficacious cuproptosis using a chemotherapeutic drug presents a promising avenue for enhancing the effectiveness of multi-modal anti-tumor treatments.

相关文献

Cold atom–atom–ion three-body recombination of 4He–4He–X− (X = H or D)

Bin-Bin Wang, Yong-Chang Han, Wei Gao, Shu-Lin Cong

2017-08-03 Paper

DOI: 10.1039/C7CP04310D

Importance of non-intrinsic platinum dissolution in Pt/C composite fuel cell catalysts

Nejc Hodnik, Francisco Ruiz-Zepeda, Martin Šala, Vid Simon Šelih, Tim Patrick Fellinger

2017-07-19 Paper

DOI: 10.1039/C7CP03192K

Role of carboxylic acid groups in the reduction of nitric oxide by carbon at low temperature, as exemplified by graphene oxide

Q. Gao, X. M. Li, J. Z. Zhou, X. X. Ruan, Q. Liu, G. R. Qian

2017-08-02 Paper

DOI: 10.1039/C7CP01541K

Interfacial structure of atomically flat polycrystalline Pt electrodes and modified Sauerbrey equation

Jutae Kim, Patrick Urchaga, Stève Baranton, Christophe Coutanceau, Gregory Jerkiewicz

2017-06-23 Paper

DOI: 10.1039/C7CP02528A

Phase separation dynamics of polydisperse colloids: a mean-field lattice-gas theory

Pablo de Castro, Peter Sollich

2017-08-02 Paper

DOI: 10.1039/C7CP04062H

Spectroscopic characterization of the on-surface induced (cyclo)dehydrogenation of a N-heteroaromatic compound on noble metal surfaces

I. Palacio, A. L. Pinardi, J. I. Martínez, A. Preobrajenski, A. Cossaro, A. Jancarik, I. Stará, I. Starý, J. Méndez, J. A. Martín-Gago, M. F. López

2017-07-31 Paper

DOI: 10.1039/C7CP03955G

Quantification of nucleobases/gold nanoparticles interactions: energetics of the interactions through apparent binding constants determination

J. M. Carnerero, A. Sánchez-Coronilla, E. I. Martín, A. Jimenez-Ruiz, R. Prado-Gotor

2017-08-02 Paper

DOI: 10.1039/C7CP03692B

The pressure–temperature phase diagram of pure Co based on first-principles calculations

Cuiping Wang, Cong Li, Jiajia Han, Lihui Yan, Bin Deng, Xingjun Liu

2017-07-24 Paper

DOI: 10.1039/C7CP03775A

Nonlinear imaging microscopy for assessing structural and photochemical modifications upon laser removal of dammar varnish on photosensitive substrates

M. Oujja, S. Psilodimitrakopoulos, E. Carrasco, M. Sanz, A. Philippidis, A. Selimis, P. Pouli, G. Filippidis, M. Castillejo

2017-08-08 Paper

DOI: 10.1039/C7CP02509B

您可能还喜欢

化合物问答

(3-氨苯基)环丙基甲酮(CAS号:162174-75-6)的主要用途是什么?

(3-氨苯基)环丙基甲酮主要用于合成化学中间体,特别是在药物化学领域作为原料。它还可以用于有机合成反应中,作为催化剂或反应物。

162174-75-6(3-Aminophenyl)(cycl...
化合物问答

如何储存亚胺菌(CAS号:136470-79-6)?

亚胺菌应储存在干燥、阴凉处,避免直接暴露于光线下。建议使用密封容器储存,防止吸潮和污染。具体的储存条件应参考产品的安全数据表(MSDS)或药品说明书。

136470-79-6Abacavir EP Impurity...
化合物问答

2-氯-2,2-二氟乙酰胺(CAS号:354-28-9)应用于哪些行业?

2-氯-2,2-二氟乙酰胺在医药、聚合物、传感器、半导体等领域有广泛应用。在医药领域,它作为中间体用于合成其他药物;在聚合物领域,用作聚合引发剂或稳定剂;在传感...

354-28-92-Chloro-2,2-difluor...
化合物问答

处理4-甲基-3-硝基-1,1-联苯(CAS号:53812-68-3)时应注意哪些实验室安全事项?

在处理4-甲基-3-硝基-1,1-联苯时,应佩戴手套、护目镜和实验室外套等个人防护装备(PPE),确保在通风橱中操作以减少吸入风险。若发生泄露,应立即使用沙子或...

53812-68-34'-Methyl-3-nitro-1,...
化合物问答

(2S)-羟基(苯基)乙酸 (2R)-N-苄基-1-(4-甲氧基苯基)丙-2-胺盐(CAS号:188690-84-8)应用于哪些行业?

该化合物广泛应用于医药、聚合物和半导体行业。在医药领域,它是某些药物中间体的重要组成部分;在聚合物领域,可用作增塑剂;在半导体行业,可用于制造光刻胶。

188690-84-8Benzeneacetic acid, ...
化合物问答

在合成中是否有芬苯哒唑砜-D3标准品(CAS号:1228182-49-7)的替代品?

芬苯哒唑砜-D3标准品的替代品可能包括类似的苯并咪唑类化合物,如芬苯哒唑本身或其非同位素标记版本。这些替代品在结构上与芬苯哒唑砜-D3相似,但在具体应用中需进行...

1228182-49-7(~2~H_3_)Methyl [5-(...
化合物问答

2-氟-4-硝基苯乙酸(CAS号:315228-19-4)通常如何合成?

2-氟-4-硝基苯乙酸可以通过一系列化学反应合成,通常是从4-氟苯胺开始,首先进行硝化反应生成4-氟-2-硝基苯胺,然后进行乙酰化反应得到目标产物。具体的合成步...

315228-19-42-(2-fluoro-4-nitrop...
化合物问答

2-氟-4-甲氧基苯乙酸(CAS号:883531-28-0)通常如何合成?

2-氟-4-甲氧基苯乙酸通常通过将4-甲氧基苯乙酸与氟化试剂(如氟化氰)反应来合成。反应通常在无水条件下进行,使用催化剂如六氟磷酸锂或四氟硼酸锂以提高选择性和产...

883531-28-02-Fluoro-4-methoxyph...
化合物问答

什么是4SC 202;4SC202(CAS号:1186222-89-8)?

4SC 202;4SC202是一种化学化合物,其化学名称为(2E)-N-(2-氨基苯基)-3-(1-{[4-(1-甲基-1H-吡唑-4-基)苯基]磺酰基}-1H...

1186222-89-8(2E)-N-(2-Aminopheny...
化合物问答

如何储存3,5-二氟苯甲酰胺(CAS号:132980-99-5)?

3,5-二氟苯甲酰胺应储存在阴凉、干燥、通风良好的地方,避免高温和直射阳光。最好使用密封的容器存储,以减少吸湿。

132980-99-53,5-Difluorobenzamid...

来源期刊

Journal of Materials Chemistry B

Journal of Materials Chemistry B
CiteScore: 12
自引率: 4.9%
年发文量: 831

Journal of Materials Chemistry A, B & C cover high quality studies across all fields of materials chemistry. The journals focus on those theoretical or experimental studies that report new understanding, applications, properties and synthesis of materials. The journals have a strong history of publishing quality reports of interest to interdisciplinary communities and providing an efficient and rigorous service through peer review and publication. The journals are led by an international team of Editors-in-Chief and Associate Editors who are all active researchers in their fields. Journal of Materials Chemistry A, B & C are separated by the intended application of the material studied. Broadly, applications in energy and sustainability are of interest to Journal of Materials Chemistry A, applications in biology and medicine are of interest to Journal of Materials Chemistry B, and applications in optical, magnetic and electronic devices are of interest to Journal of Materials Chemistry C. More than one Journal of Materials Chemistry journal may be suitable for certain fields and researchers are encouraged to submit their paper to the journal that they feel best fits for their particular article. Example topic areas within the scope of Journal of Materials Chemistry B are listed below. This list is neither exhaustive nor exclusive. Antifouling coatings Biocompatible materials Bioelectronics Bioimaging Biomimetics Biomineralisation Bionics Biosensors Diagnostics Drug delivery Gene delivery Immunobiology Nanomedicine Regenerative medicine & Tissue engineering Scaffolds Soft robotics Stem cells Therapeutic devices image block All articles published in Journal of Materials Chemistry B from 2019 onwards will be indexed in MEDLINE®. Articles that primarily focus on providing insight into the underlying science and performance of biomaterials within a biological environment are more suited to our companion journal, Biomaterials Science.

推荐供应商

免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。